InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Lundberg Jan M, Director. Director active across 1 companies, notably Ardelyx, INC.. In total, 3 reports have been published. The latest transaction was disclosed on 15 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
091,240 shares0
Common Stock
SEC:0001567619-22-013083:0·
07,181 shares0
Common Stock
SEC:0001567619-21-012427·
07,181 shares0
Common Stock
SEC:0001567619-21-012427:0·
3 of 3 declarations
About Lundberg Jan M
Jan M. Lundberg is a Director of ARDELYX, INC. In this role, he participates in the governance of the company and strategic direction. ARDELYX, INC. is a biopharmaceutical company focused on developing treatments for gastrointestinal diseases. Jan brings valuable expertise in leadership and strategy.
